452 results on '"Bhatt, Ankeet S."'
Search Results
2. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
3. Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
4. Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood
5. Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Hospitalized Patients With Heart Failure: Insights From the Veterans Affairs Healthcare System
6. Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System
7. Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study
8. County-Level Variation in Triple Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction
9. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
10. Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
11. Eligibility and Potential Benefit of Transcatheter Edge-to-Edge Repair in a Contemporary Cohort With Heart Failure: Evidence From a Large Integrated Health Care Delivery System
12. How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical Therapy
13. Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry
14. Association Between Participation in a Heart Failure Telemonitoring Program and Health Care Utilization and Death Within an Integrated Health Care Delivery System
15. Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER
16. Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial
17. Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial
18. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
19. Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
20. Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care
21. Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters
22. Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
23. Applying natural language processing to identify emergency department and observation encounters for worsening heart failure.
24. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America
25. Cost and Value in Contemporary Heart Failure Clinical Guidance Documents
26. Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial
27. Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
28. Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination
29. Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials
30. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry
31. Hospitalization of Patients With (But Not for) Heart Failure: An Opportunity for Accelerated Guideline-Directed Medical Therapy Optimization?
32. Incidence and Outcomes of Pneumonia in Patients With Heart Failure
33. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
34. Accuracy of ICD-10 Diagnostic Codes to Identify COVID-19 Among Hospitalized Patients
35. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
36. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
37. Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination
38. Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2:Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
39. Electronic nudges increase influenza vaccination utilization after myocardial infarction:the nationwide NUDGE-FLU implementation trial
40. Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit.
41. Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
42. Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
43. Nudging a Nation — The Danish NUDGE Trial Concept
44. Effective medications can work only in patients who take them: implications for post acute heart failure care
45. Gamified Behavioral Science Intervention to Enhance Trial Enrollment: An Embedded Study Within the FINEARTS-HF Trial
46. Low-Density Lipoprotein Cholesterol Control as a Performance Measure: A National Analysis of the VHA
47. Resource use among patients with transcatheter cardiac valve procedures admitted to contemporary cardiac intensive care units: insights from CCCTN
48. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction
49. Impact of COVID‐19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial
50. Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.